Evidence map›Paper›PMID 24825442›Full record

ArticleTissue engineering. Part A2014

Engineering de novo assembly of fetal pulmonary organoids.

Mark J Mondrinos, Peter L Jones, Christine M Finck, Peter I Lelkes

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Extracellular Microenvironmental Control for Organoid Assembly.Tissue engineering. Part B, Reviews · 2022
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Through the Looking Glass:Applied in vitro toxicology · 2018
    Review
  14. Modeling of Autism Using Organoid Technology.Molecular neurobiology · 2017
    Review
  15. Review
  16. Review
  17. Lung organoids: current uses and future promise.Development (Cambridge, England) · 2017
    Review
  18. Kidney Organoids: A Translational Journey.Trends in molecular medicine · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mark J Mondrinos1 Department of Bioengineering, Temple University , Philadelphia, Pennsylvania.
Peter L Jones
Christine M Finck
Peter I Lelkes
Temple University · USConnecticut Children's Medical Center · US

Funding

Coordination of pulmonary vascular development by Prx1R01HL079196 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI JONES, PETER LLOYD · 2005 to 2008
$1.5M
Biotechnology Based Fetal Pulmonary Tissue EngineeringR21EB003520 · NIBIB · DREXEL UNIVERSITY · PI FINCK, CHRISTINE M · 2005 to 2006
$407k
Prx homebox genes in pulmonary vascular homeostasisR01HL068798 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI JONES, PETER LLOYD · 2002 to 2006
$383k
NHLBI NIH HHS R01HL079196-02NHLBI NIH HHS R01 HL68798-01NIBIB NIH HHS 1R21 EB-003520-01A1
6 · The paper itself

Abstract

Induction of morphogenesis by competent lung progenitor cells in a 3D environment is a central goal of pulmonary tissue engineering, yet little is known about the microenvironmental signals required to induce de novo assembly of alveolar-like tissue in vitro. In extending our previous reports of alveolar-like tissue formation by fetal pulmonary cells stimulated by exogenous fibroblast growth factors (FGFs), we identified some of the key endogenous mediators of FGF-driven morphogenesis (organoid assembly), for example, epithelial sacculation, endothelial network assembly, and epithelial-endothelial interfacing. Sequestration of endogenously secreted vascular endothelial growth factor-A (VEGF-A) potently inhibited endothelial network formation, with little or no effect on epithelial morphogenesis. Inhibition of endogenous sonic hedgehog (SHH) partially attenuated FGF-driven endothelial network formation, while the addition of exogenous SHH in the absence of FGFs was able to induce epithelial and endothelial morphogenesis, although with distinct morphological characteristics. Notably, SHH-induced endothelial networks exhibited fewer branch points, reduced sprouting behavior, and a periendothelial extracellular matrix (ECM) virtually devoid of tenascin-C (TN-C). By contrast, focal deposition of endogenous TN-C was observed in the ECM-surrounding endothelial networks of FGF-induced organoids, especially around sprouting tips. In the FGF-induced organoids, TN-C was also observed in the clefts of sacculated epithelium and at the epithelial-endothelial interface. In support of a critical role in the formation of alveolar-like tissue in vitro, TN-C blocking inhibited endothelial network formation and epithelial sacculation. Upon engraftment of in-vitro-generated pulmonary organoids beneath the renal capsule of syngeneic mice, robust neovascularization occurred in 5 days with a large contribution of patent vessels from engrafted organoids, providing proof of principle for exploring intrapulmonary engraftment of prevascularized hydrogel constructs. Expression of proSpC, VEGF-A, and TN-C following 1 week in vivo mirrored the patterns observed in vitro. Taken together, these findings advance our understanding of endogenous growth factor and ECM signals important for de novo formation of pulmonary tissue structures in vitro and demonstrate the potential of an organoid-based approach to lung tissue augmentation.

Indexed as

AnimalsCells, CulturedIntercellular Signaling Peptides and ProteinsLungMiceMorphogenesisOrgan Culture TechniquesOrganoidsStem Cell NicheStem CellsTissue EngineeringIntercellular Signaling Peptides and Proteins

Identifiers

PMID24825442
PMCPMC4229698
OpenAlexW2321259244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.